Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue ...

Atrial fibrillation, or A-fib , is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even premature death.Author ...

Medical management is common in people with AFib, too, since lifestyle changes are usually not enough to control the condition. Treatment plans for AFib may include a combination of several ...

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

According to market research firm International Data Corp. (IDC), wearables are expected to grow 3.9% in 2025 to reach about ...

National Non-Smoking Week is an annual occasion to acknowledge the harms of tobacco industry products and to commit to individual and societal action to reduce them. Unfortunately, this year, tobacco ...

Consumer devices like fitness trackers are great at tracking how long you sleep and identifying patterns in different sleep ...

ImmunoPrecise Antibodies Ltd. (IPA) has developed a new class of GLP-1 therapies entirely through artificial intelligence, designed to enhance efficacy, safety, therapy longevity, and patient ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...